Arbor Launches Third Product
Raleigh pediatric pharmaceutical company Arbor Pharmaceuticals has launched a non-antibiotic oral solution to reduce children's ear infections.
The company said its new prescription-only dietary product, XYLAREX, can be administered daily to children as young as six months of age. This is Arbor's third product introduction since the privately held firm was founded only two years ago.
"XYLAREX is a very important product as it represents a first-in-class non-drug therapy with the potential to positively impact the lives of millions of children suffering from recurrent ear infections," said Jarrett Disbrow, president and CEO of Arbor.